Federation Des Caisses Desjardins Du Quebec Lexaria Bioscience Corp. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $19 Billion
- Q1 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 382 shares of LEXX stock, worth $374. This represents 0.0% of its overall portfolio holdings.
Number of Shares
382Holding current value
$374% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LEXX
# of Institutions
24Shares Held
1.28MCall Options Held
0Put Options Held
0-
Invenomic Capital Management LP Boston, MA550KShares$538,9480.05% of portfolio
-
Geode Capital Management, LLC Boston, MA172KShares$169,0070.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6130KShares$127,4240.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA128KShares$125,3130.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL61.3KShares$60,0250.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $5.83M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...